Author

Christopher R. Starr

University of Alabama at BirminghamORCID 0000-0002-2038-481XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Molecular Biology· 1 Neuroscience· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Research Focus:differential expression· 3 Approach:experimental assay· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Marina S. GorbatyukiD· 3 shared Assylbek A. ZhylkibayeviD· 2 shared James A. MobleyiD· 2 shared Maria B. GrantiD· 2 shared Oleg S. GorbatyukiD· 2 shared Alli M. Nuotio-AntariD· 1 shared C. Garren Hester· 1 shared Catherine Bowes RickmaniD· 1 shared

Activity by Year

2024-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Marina S. GorbatyukORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with alpha-Synucleinopathy

Assylbek A. Zhylkibayev, Christopher R. Starr, Mohammed Iqbal Hossain, Sandeep K Barodia, Shaida A. Andrabi, Maria B. Grant, Venkatram R. Atigadda, Marina S. Gorbatyuk, Oleg S. Gorbatyuk

This study shows that activating RXR reduces alpha-synuclein pathology and neuroinflammation in a mouse model of Parkinson's disease.

Cells · May 9, 2025Peer-reviewedNeuroscience

Truncated Complement Factor H Y402 Gene Therapy Cures C3 Glomerulonephritis

Lindsey A. Chew, Daniel Grigsby, C. Garren Hester, Joshua Amason, W. Kyle McPherson, Edward J. Flynn, Meike Visel, Christopher R. Starr, John G. Flannery, Tylor R. Lewis, Catherine Bowes Rickman

This study shows that AAV-delivered truncated CFH gene therapy can reverse C3G in mice and suggests its potential for treating AMD.

Molecular Therapy · Apr 24, 2025Peer-reviewedPathology

Glucose-Sensing ChREBP Protein in the Pathogenesis of Diabetic Retinopathy

Christopher R. Starr, Assylbek A. Zhylkibayev, Oleg S. Gorbatyuk, Alli M. Nuotio-Antar, James A. Mobley, Maria B. Grant, Marina S. Gorbatyuk

This study investigates the role of ChREBP in diabetic retinopathy, finding its overexpression leads to metabolic reprogramming and retinal dysfunction in mice.

Cells · Jan 13, 2025Peer-reviewedCell Biology

Comparative Proteomic Study of Retinal Ganglion Cells Undergoing Various Types of Cellular Stressors

Christopher R. Starr, James A. Mobley, Marina S. Gorbatyuk

This study compares proteomic changes in retinal ganglion cells under glutamate excitotoxicity and optic nerve crush, identifying unique and shared alterations in protein profiles.

Experimental Eye Research · Aug 8, 2024Peer-reviewedMolecular Biology